Category Archives: Immunosuppressants

Person to Person Hair Transplants Revisited

Modern hair transplants generally produce quality results. However, the biggest disadvantage of hair restoration remains the fact that people have limited donor hair at the back of their scalps in the safe “permanent” zone.

Men with large bald areas will usually not get great results from a hair transplant unless their coverage expectations are modest. Meaning that they do not mind seeing barren scalp on days when their hair becomes wet in the rain or disheveled by the wind.

Hence the common question: “Can you transplant hair from one person to another?”. i.e., allogeneic hair transplants.

Person to Person Hair Transplants

Because of this lack of sufficient donor hair supply, one would wonder why person to person hair transplants have not become more common?

The obvious and most cited explanation from hair transplant surgeons is that due to the requirement of taking anti-rejection medications (immunosuppressants) for life, person to person hair transplants are almost never approved. Taking immunosuppressants for life carries significant health risks.

However, from what I have read in numerous organ transplant stories, death from taking anti-rejection drugs is rare. People monitor themselves daily when taking such drugs. I wonder how many people below the age of 60 die from the side effects of taking immunosuppressants?

Moreover, it seems like physicians are getting closer to weaning organ recipients off of immunosuppressants entirely. That would be a miracle. In any case, even if proven to be very safe in the long run, most people would not want to take immune supressing drugs just to get more scalp hair. Therefore, I was not planning on writing a post about person to person hair transplants.

Jahoda and Reynolds: First Successful Hair Transplant Between People

However, yesterday, I happened to reread the summary of a groundbreaking experiment from 1999 by Dr. Colin Jahoda on his wife Dr. Amanda Reynolds. The actual study was published in Nature.

Dr. Jahoda transplanted several of his scalp hairs to Dr. Reynolds arm, and four hairs then grew on Dr. Reynolds arm. I read about this well known experiment numerous times in the past, but forgot to ever check if Dr. Reynolds took immunosuppressants. Then I read the below in the above linked article and felt like a lightening bolt struck me:

Apart from its theoretical use in cosmetic medicine, the experiment reveals that: hair follicles are one of the rare tissues apparently capable of being transplanted from one body to another without rejection. Why evolution has endowed them with such “immune privilege” is a mystery.

This makes me wonder why more surgeons have not attempted person to person scalp hair to scalp hair transplants? In one of my pasts post on transplants and immunosuppressants, one commentator suggested that you could never get another living person to donate his or her hair to you. I think that is absolutely incorrect. If I had a very full thick head of hair and someone offered me say $100,000 to donate 20 percent of my scalp hair, I would be more than happy to do so. If it were a family member, I would do it for free.

Going back to the above article, it seems like Dr. Jahoda transferred dermal sheath cells rather than actual hair. However, the full hairs were extracted from Dr. Jahoda’s scalp prior to extraction of the dermal sheath cells from them via the use of a powerful microscope. Dr. Jahoda holds a patent on this procedure. The doctor did have some doubts about normal hair cycling feasibility after one round of shedding was over.

Success not Guaranteed

I was excited by my finding after re-reading the summary of the Jahoda experiment. Nevertheless, considering that it all happened in 1999, I think there must be some sound explanation behind person to person transplants never taking off.

I did some more googling on this, and came across an interesting comment from 2009 that is pasted below. Usually, I do not like to quote comments from internet based forum members. However, this one from Marion Landan on the regrowhair site seems somewhat legitimate and sincere to me:

“Just want to correct what you are saying about hair transplanting from another person. The people do not have to be identical twins or even related to one another. I have been told by a retiring hair transplant expert who tried some of these surgeries that sometimes it works and sometimes it does not.

Just as there was a learning curve for transfusing blood, there are things not understood about why hair can be transplanted sometimes from an unrelated donor, and sometimes can’t even be transplanted between identical twins (possibly with the twins the bald brother had an infection that caused his original hair loss, after transplantation from his brother, his head swelled up and rejected the new hair). I have also been told that hair transplanting between people was made illegal in the United States several years ago — so doctors no longer try it.”

Why would this have been made illegal? Were there serious side effects involved?

Reducing Rejection Rates after Transplant

Half of Dr. Siemionow’s prediction came true in 2015: first ever skull and scalp transplant.

Finally, it seems like certain commonalities between donor and recipient might increase the likelihood of survival of organs and tissues after a transplant. These can include blood type, certain common genes and more. Transplant survival rates with or without anti-rejection medication will continue to improve as researchers uncover more such details.

Immunosuppressants and Face and Organ Transplants

For many years, I have followed news in the fields of organ transplantation, limb transplantation and face transplantation with keen interest. Each year, achievements in those fields become evermore impressive. The use of immunosuppressants is also becoming safer and more strategic.

Scientists and doctors in countries as dispersed as China, India, Japan, Spain, Thailand, Turkey and the US all seem to be producing groundbreaking results and innovations in the field of transplantation.

Worldwide Face, Organ and Limb Transplants

Most developing countries do not have sizable local biotech and other new-age industries. However, the vast majority have numerous hospitals, usually including at least several world class ones. Poor citizens in third world countries often have no choice other than to get transplants at local hospitals. This enables local doctors and surgeons to gain significant experience in organ transplantation.

In the field of heart transplantation, India is especially important. In the field of full face transplantation, while the US leads the way, Turkey is also very important. The world’s first face transplant was done in Spain in 2010. China has also achieved some significant milestones in face transplants. It is supposedly also the first country where a penis transplant was successfully undertaken. Unfortunately, the patient did not want it after all that hard work and stress! You can read about the latest developments in Japan towards the bottom of this post.

One frequent question on hair loss forums is why people with significant balding and limited donor hair do not get hair transplants in which the donor hair comes from another person. Update: see allogeneic hair transplantation success.

The reason given is that in order for such a procedure to be successful, one would have to take immunosuppressive drugs (i.e., anti-rejection medicine) for a lifetime. This is not a risk worth taking for a cosmetic problem such as hair loss. Perhaps person-to-person hair transplants are also far more complex, since each hair being moved is a unique organ?

Immunosuppressants after Organ Transplants

Like almost anyone else, I feel that taking immunosuppressive drugs to get hair transplanted from another person was foolish. However, recently, I started getting curious as to how dangerous these immunosuppressive drugs really turn out to be.

Do people below the age of 65 die more frequently from diseases and infections after organ transplantation? Is it because their immune systems become weaker when they are on immunosuppressants?

Although I could not find too much information on fatalities, there are quite a few sites with warnings about side effects of taking these drugs. A large number of side effects are not especially dangerous, but there are some warnings of potential higher risks of cancer. However, this correlation with higher rates of cancer is not entirely clear cut.

One surprising thing I found was that immunosuppressants are often even prescribed for problems such as Eczema and Psoriasis for people with severe cases of these skin cell disorders.

It should also be noted that scientists have increasingly improved strategies in having organ transplant recipients taper off high-dose immunosuppressants. Not to mention the availability of new drugs, biologics and immunosupresssants.

Interesting Organ, Limb and Face Transplant Results

The duration of time for which organ transplants last has in general gone up for all organ types over the years. Some of the unexpectedly long-lasting results are particularly interesting. Especially when considering that the patient has to take immunosuppressant drugs throughout his or her life. Usually at a lower dose after the first year or so post transplant.

Some of my favorite recent transplant related stories:

British grandmother whose new kidney was still going strong 40 years post transplant as of 2014.

When it comes to the heart, Dick Cheney should be inspirational to all. Money and access to great surgeons helps of course. But rather then being envious, for the sake of science I hope that this man lives many more years. A good post transplant interview with Cheney.

US man with rare double hand transplant in 2010 still going strong five years later.

Heart transplant at the age of 2, still here at 32 as of 2014.

British man breaks world record in 2013 after surviving 31 years post heart transplant.

US face transplant recipient Mitch Hunter’s excellent Reddit “Ask Me Anything.” Also see photos: Soldier Mitch Hunter.